Key result
Resveratrol increases endothelial eNOS expression up to ~2.8-fold and stimulates nitric oxide production.
Answers are grounded in this paper and cite their sources.
BACKGROUND: Estrogens can upregulate endothelial nitric oxide synthase (eNOS) in human endothelial cells by increasing eNOS promoter activity and enhancing the binding activity of the transcription factor Sp1. Resveratrol, a polyphenolic phytoalexin found in grapes and wine, has been reported to act as an agonist at the estrogen receptor. Therefore, we tested the effect of this putative phytoestrogen on eNOS expression in human endothelial cells. METHODS AND RESULTS: Incubation of human umbilical vein endothelial cells (HUVEC) and HUVEC-derived EA.hy 926 cells with resveratrol for 24 to 72 hours upregulated eNOS mRNA expression in a time- and concentration-dependent manner (up to 2.8-fold). eNOS protein expression and eNOS-derived NO production were also increased after long-term incubation with resveratrol. Resveratrol increased the activity of the eNOS promoter (3.5-kb fragment) in a concentration-dependent fashion, with the essential trans-stimulated sequence being located in the proximal 263 bp of the promoter sequence. In addition, eNOS mRNA was stabilized by resveratrol. The effect of resveratrol on eNOS expression was not modified by the estrogen receptor antagonists ICI 182780 and RU 58668. In electrophoretic mobility shift assays, nuclear extracts from resveratrol-incubated EA.hy 926 cells showed no enhanced binding activity of the eNOS promoter-relevant transcription factors Sp1, GATA, PEA3, YY1, or Elf-1. In addition to its long-term effects on eNOS expression, resveratrol also enhanced the production of bioactive NO in the short-term (after a 2-minute incubation). CONCLUSIONS: In concert with other effects, the stimulation of eNOS expression and activity may contribute to the cardiovascular protective effects attributed to resveratrol.
No takes yet. Share an insight, caveat, or question.
Wallerath et al. (2002) studied Endothelial nitric oxide synthase expression and activity in human endothelial cells. Resveratrol was evaluated on Endothelial nitric oxide synthase (eNOS) mRNA and protein expression, promoter activity, and NO production (Up to 2.8-fold increase in eNOS mRNA expression). Resveratrol incubation for 24 to 72 hours upregulated eNOS mRNA expression up to 2.8-fold and increased eNOS protein expression and NO production in human endothelial cells.
Synapse has enriched 10 related papers. Consider them for comparative context: